AEterna Zentaris CEO to Take Part in Panel Discussion on Cancer Therapy at Upcoming RBC Capital Markets Healthcare Conference in
February 23 2010 - 8:00AM
PR Newswire (US)
QUEBEC CITY, Feb. 23 /PRNewswire-FirstCall/ -- AEterna Zentaris
Inc. (NASDAQ:AEZSNASDAQ:TSX:NASDAQ:AEZ), (the "Company"), a
late-stage drug development company specialized in oncology and
endocrinology, today announced that its President and CEO, Juergen
Engel, Ph.D., will take part in a panel discussion titled, "Cancer:
Improving Treatment through Combination Therapy" at the RBC Capital
Markets Healthcare Conference on Wednesday, March 3, 2010, from
8:00 am to 8:55 am (eastern) in the Holmes I Room of The New York
Palace Hotel in New York City. A live audio webcast of the panel
discussion will be available in the Investors section of the
Company's website at http://www.aezsinc.com/. A replay of the
webcast will also be available on its website for a period of 30
days. About AEterna Zentaris Inc. AEterna Zentaris Inc. is a
late-stage drug development company specialized in oncology and
endocrinology. News releases and additional information are
available at http://www.aezsinc.com/. DATASOURCE: AETERNA ZENTARIS
INC. CONTACT: Investor Relations: Ginette Vallieres, Investor
Relations Coordinator, (418) 652-8525 ext. 265, ; Media Relations:
Paul Burroughs, Director of Communications, (418) 652-8525 ext.
406,
Copyright
Aeterna Zentaris (NASDAQ:AEZS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Aeterna Zentaris (NASDAQ:AEZS)
Historical Stock Chart
From Jul 2023 to Jul 2024